Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Maurizio Benucci and Luca Quartuccio.
Maurizio Benucci
Connection Strength
1.928
Luca Quartuccio
  1. Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine. 2020 05; 87(3):195-197.
    View in: PubMed
    Score: 0.880
  2. Answer to Vieira et al. "Cytokine profile as a prognostic tool in coronavirus disease 2019". Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006. Joint Bone Spine. 2021 01; 88(1):105076.
    View in: PubMed
    Score: 0.226
  3. Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al. Ann Rheum Dis. 2020 Aug 04.
    View in: PubMed
    Score: 0.224
  4. Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Ann Rheum Dis. 2020 Jul 06.
    View in: PubMed
    Score: 0.223
  5. Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome. Joint Bone Spine. 2020 05; 87(3):191-193.
    View in: PubMed
    Score: 0.220
  6. COVID 19: a clue from innate immunity. Immunol Res. 2020 06; 68(3):161-168.
    View in: PubMed
    Score: 0.055
  7. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Isr Med Assoc J. 2020 04; 22(4):203-210.
    View in: PubMed
    Score: 0.055
  8. Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. Clin Exp Rheumatol. 2018 Jan-Feb; 36(1):44-49.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.